ArticleJournal of gastrointestinal cancer2019

Treatment Patterns and Outcomes in Patients with KRAS Wild-Type Metastatic Colorectal Cancer Treated in First Line with Bevacizumab- or Cetuximab-Containing Regimens.

Arthur C Houts et al.PubMed ↗Publisher ↗

No numbers read from the abstract.